| Code | 0571D | ||||||||||
| MA number | EU/1/04/292/014 | ||||||||||
| Product Form: | gra cps 30x2,5 mg (HDPE fľ.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Amgen Europe B.V., Netherland | ||||||||||
| Therapeutic Class: | 56 - HORMONA (LIEČIVA S HORMONÁLNOU AKTIVITOU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 48 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 22.10.2004 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC Mimpara klinická štúdia 25 3 2013.pdf
|
| Safety feature | Yes |
| Data update: | 09.03.2021 |
